Evidence map›Paper›PMID 40832018›Full record

ArticleFrontiers in public health2025

COVID-19 global risk evaluation: rankings, reducing surveillance bias, and infodemic.

Michał P Michalak, Elżbieta Węglińska, Agnieszka Kulawik, Jack Cordes, Michał Lupa, Andrzej Leśniak

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michał P MichalakFaculty of Geology, Geophysics and Environmental Protection, AGH University of Krakow, Kraków, Poland.
Elżbieta WęglińskaFaculty of Geology, Geophysics and Environmental Protection, AGH University of Krakow, Kraków, Poland.
Agnieszka KulawikFaculty of Science and Technology, University of Silesia in Katowice, Katowice, Poland.
Jack CordesDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States.
Michał LupaFaculty of Space Technologies, AGH University of Krakow, Kraków, Poland.
Andrzej LeśniakFaculty of Geology, Geophysics and Environmental Protection, AGH University of Krakow, Kraków, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examines how public health institutions estimate regional COVID-19 burdens, pursuing two primary objectives: (1) to analyze the methodologies employed for regional risk assessment, and (2) to perform spatial and Spearman rank correlation analyses of risk metrics that incorporate testing data across 101 countries. Classification methods used to assess COVID-19 risk often treat testing as a secondary, qualitative factor, overlooking its value as a quantitative input. Integrating testing data with case counts can improve the accuracy of regional infection probability estimates. Spatial analysis revealed that probabilistic metrics-such as the local probability of infection-showed stronger spatial synchronization of epidemic patterns compared to observed-to-expected case ratios. The death-to-population ratio displayed the strongest positive correlation with the observed-to-expected cases ratio. Conversely, the case fatality rate exhibited only a weak positive correlation with probabilistic metrics, though these correlations were not consistently statistically significant. The findings underscore the potential of probabilistic metrics, such as the local probability of infection, in predicting COVID-19 risk. Further research is warranted to explore the predictive capacity of probabilistic metrics concerning death-related outcomes.

Indexed as

COVID-19Global HealthBiasHumansRisk AssessmentSARS-CoV-2global positivitylocal positivityrankingspearman correlationsurveillance bias

Identifiers

PMID40832018
PMCPMC12358430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.